Lisata Therapeutics, Inc. (LSTA): Cash & Equivalents
$15.96M
As of 2025-12-31
$10.44M
As of 2026-06-30
-20.8%
3-year compound annual growth
-0.7%
5-year compound annual growth
-2.4%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.96M | -1.6% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $16.21M | -28.3% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $22.59M | -29.7% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $32.15M | +30.5% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $24.65M | +49.3% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $16.51M | +17.7% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $14.03M | +36.2% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $10.30M | -64.7% | 2020-03-05, Balance as of period end |
| 2017-12-31 | $29.16M | +312.1% | 2019-03-14, Balance as of period end |
| 2016-12-31 | $7.08M | -65.2% | 2018-03-22, Balance as of period end |
| 2015-12-31 | $20.32M | +6.0% | 2017-03-17, Balance as of period end |
| 2014-12-31 | $19.17M | -58.4% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $46.13M | +235.8% | 2015-03-02, Balance as of period end |
| 2012-12-31 | $13.74M | +249.1% | 2014-03-13, Balance as of period end |
| 2011-12-31 | $3.94M | -74.8% | 2013-03-11, Balance as of period end |
| 2010-12-31 | $15.61M | n/a | 2012-03-20, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $15.96M | -1.6% |
| Clene Inc. (CLNN) | 2025-12-31 | $5.19M | -57.3% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $3.06M | -16.8% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $69.6K | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.18M | -59.8% |
| iBio, Inc. (IBIO) | 2026-06-30 | $56.40M | +557.1% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $681.5K | +174.4% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $4.98M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $14.69M | -24.8% |
Compare LSTA, CLNN, SER, RGBP side by side · Screen every company in Pharmaceutical Preparations ↗